Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application

• Published in: Journal of Parkinson's disease Vol. 12; no. 3; pp. 871 - 884
• Main Authors: Hiramatsu, Satoe, Morizane, Asuka, Kikuchi, Tetsuhiro, Doi, Daisuke, Yoshida, Kenji, Takahashi, Jun
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.01.2022; IOS Press BV; IOS Press
• Subjects: 6-Hydroxydopamine; Animals; Cell Differentiation; Cell suspensions; Cell therapy; Cryopreservation; Cryopreservation - methods; Dopamine - metabolism; Dopamine receptors; Dopaminergic Neurons - metabolism; Fetuses; Freezing; Humans; Induced Pluripotent Stem Cells - metabolism; Movement disorders; Neurodegenerative diseases; Neurospheres; Oxidopamine - metabolism; Parkinson Disease - therapy; Parkinson's disease; Pluripotency; Rats; Research Report; Rotational behavior; Stem cells; Thawing; Transplantation; induced pluripotent stem cells; dopaminergic neuron; Cryopreservation; cell-based therapy; Parkinson’s disease; neurosphere
• ISSN: 1877-7171; 1877-718X
• DOI: 10.3233/JPD-212934

Background: Pluripotent stem cell (PSC)-derived dopaminergic (DA) neurons are an expected source of cell therapy for Parkinson’s disease. The transplantation of cell aggregates or neurospheres, instead of a single cell suspension has several advantages, such as keeping the 3D structure of the donor cells and ease of handling. For this PSC-based therapy to become a widely available treatment, cryopreservation of the final product is critical in the manufacturing process. However, cryopreserving cell aggregates is more complicated than cryopreserving single cell suspensions. Previous studies showed poor survival of the DA neurons after the transplantation of cryopreserved fetal ventral-mesencephalic tissues. Objective: To achieve the cryopreservation of induced pluripotent stem cell (iPSC)-derived DA neurospheres toward clinical application. Methods: We cryopreserved iPSC-derived DA neurospheres in various clinically applicable cryopreservation media and freezing protocols and assessed viability and neurite extension. We evaluated the population and neuronal function of cryopreserved cells by the selected method in vitro. We also injected the cells into 6-hydroxydopamine (6-OHDA) lesioned rats, and assessed their survival, maturation and function in vivo. Results: The iPSC-derived DA neurospheres cryopreserved by Proton Freezer in the cryopreservation medium Bambanker hRM (BBK) showed favorable viability after thawing and had equivalent expression of DA-specific markers, dopamine secretion, and electrophysiological activity as fresh spheres. When transplanted into 6-OHDA-lesioned rats, the cryopreserved cells survived and differentiated into mature DA neurons, resulting in improved abnormal rotational behavior. Conclusion: These results show that the combination of BBK and Proton Freezer is suitable for the cryopreservation of iPSC-derived DA neurospheres.